Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.10.012Source: DataRank Database

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies is a research paper published in Biochemical and Biophysical Research Communications (2020). On theSindex it has a DataRank of 0. It has been cited 220 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access220 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 4.30)OA: hybridTopics (68)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Hejun Liu,Nicholas C. Wu ORCID,Ian A. Wilson ORCID,Meng Yuan ORCID

Live enrichment

PubMed:33069360 PMC:PMC7547570 OpenAlex:https://openalex.org/W3092501606

NIAID NIH HHS

Grant: P01 AI110657

NIAID NIH HHS

Grant: R00 AI139445

NIA NIH HHS

Grant: K01 AG044462

National Institutes of Health

Grant: 4R00AI139445-03

MECHANISTIC UNDERSTANDING OF INFLUENZA-HOST INTERACTIONS FROM A ZOONOTIC PERSPECTIVE

National Institutes of Health

Grant: 2P01AI110657-06

Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Bill and Melinda Gates Foundation

FWCI

4.30

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bbrc.2020.10.012

publisherhttps://doi.org/10.1016/j.bbrc.2020.10.012

publisherhttps://api.elsevier.com/content/article/PII:S0006291X20319215?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0006291X20319215?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33069360

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies0301 basic medicine03 medical and health sciencesAngiotensin-Converting Enzyme 2Antibodies, NeutralizingAntibodies, ViralBinding SitesHumansProtein BindingProtein DomainsReceptors, VirusSARS-CoV-2Spike Glycoprotein, Coronavirus

MeSH Terms

Protein DomainsAngiotensin-Converting Enzyme 2SARS-CoV-2Antibodies, ViralBinding SitesHumansProtein BindingReceptors, VirusAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

VirologyMonoclonal antibodyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PandemicCoronavirus disease 2019 (COVID-19)Viral entryReceptorNeutralizationVirusBiologySars virus2019-20 coronavirus outbreakBinding domainBinding siteImmunologyMedicineViral replicationOutbreakGeneticsEpitopesSARS-CovAntibody AvidityNeutralizing AntibodiesCross-neutralizationReceptor Binding Domain (Rbd)Sars-cov-2Germline-Encoded MotifsRbd Natural MutationsBinding SitesBiophysicsCell BiologyAntibodies, ViralBiochemistryAntibodies, NeutralizingArticleProtein DomainsSpike Glycoprotein, CoronavirusHumansReceptors, VirusAngiotensin-Converting Enzyme 2Molecular BiologyProtein Binding

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699.v1figshare

Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815699figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708.v1figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702figshare

Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815702.v1figshare

Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815708figshare

Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants

10.6084/m9.figshare.16815705.v1figshare

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

FAIR Checklist

Authors (4)

Funding (8 grants)

Impact

Open Access

Topics

Linked Datasets (8)

Annotations (Europe PMC)